Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,issuanceOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,currency,esgPopulated,tradeable,exchangeDataDelayedBy,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,exchange,marketState,market,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jul 30, 2019) 4","Short Ratio (Jul 30, 2019) 4","Short % of Float (Jul 30, 2019) 4","Short % of Shares Outstanding (Jul 30, 2019) 4","Shares Short (prior month Jun 27, 2019) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,DYSL,11073000,15002900,140000,,-119000,1267000,-90000,3819000,3918000,-41000,-41000,,-78000,,,,-25000,11051000,11092000,7133000,-78000,,-94000,-90000,627000,22233000,12039000,17521000,163000,30827000,9000,511000,321000,5821000,-5232000,4116000,268000,7836000,4044000,1189000,-997000,7593000,12670000,6940000,3862000,4646000,2491000,88000.0,-214000.0,1778000.0,-1471000.0,222000.0,-251000.0,-3249000.0,-9000.0,1443000.0,364000.0,-202000.0,846000.0,215000.0,-214000.0,,4834000,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.28000003,0.34146345,0.82 - 2.75,-1.65,-0.59999996,0.82,2.75,1565222400,1565726400,1565726400,1565726400,-0.022,0.0,1.1 - 1.1,1.1,0.0,0.0,270,14,finmb_415118,Other OTC,Dynasil Corporation of America,USD,1671,450,1.184,1.1941667,-0.09416664,-0.07885552,1.2183334,-0.11833334,-0.09712723,16503190,0.9290541,15,America/New_York,EDT,-14400000,4,PNK,REGULAR,us_market,DYNASIL CORP OF AMERICA,1.1,1630423898,0.0,1.09,1.1,1.1,2650,0.28,,,2.75,0.82,1.1942,1.2183,1.67k,450,15M,,7.43M,50.03%,0.00%,12.57k,0.17,0.13%,0.07%,47.37k,,,,,,0.00%,"Aug 07, 2019",,2:1,"Oct 30, 1996","Sep 29, 2019","Sep 29, 2019",-0.85%,0.03%,0.02%,-1.91%,43.7M,2.56,3.30%,16.07M,1.43M,-370k,-0.0220,,268k,0.02,6.03M,32.10,1.62,1.18,-508k,-1.32M,Value,02458,Technology,207,"Dynasil Corporation of America develops, markets, manufactures, and sells detection, sensing, and analysis technology and optical components in the United States, Asia, Europe, and internationally. It operates through Optics, Innovation and Development, and Biomedical segments. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays in the medical, industrial, and homeland security/defense sectors. The Innovation and Development segment develops advanced technology in materials, sensors, and prototype instruments that detect or measure radiation, light, magnetism, or sound for use in security, medical, and industrial applications. The Biomedical segment engages in the development of tissue sealant products. The company distributes its products through direct sales and marketing staff, as well as through manufacturer's representatives and distributors. Dynasil Corporation of America was founded in 1960 and is headquartered in Newton, Massachusetts.",Newton,617-668-6855,MA,1577750400,United States,http://www.dynasil.com,86400,313 Washington Street,617-668-6992,Scientific & Technical Instruments,Suite 403
t-1,DYSL,14414000,15002900,162000,,-202000,1270000,-263000,4090000,4106000,-146000,-146000,,-56000,,,,66000,11090000,11236000,6984000,-56000,,-268000,-263000,665000,22153000,9877000,20943000,33000,32090000,9000,599000,381000,5864000,-1818000,4188000,519000,7669000,4128000,1431000,-832000,7762000,13611000,7831000,1797000,4544000,2544000,349000.0,-118000.0,729000.0,733000.0,331000.0,169000.0,-3249000.0,-17000.0,-429000.0,363000.0,-66000.0,-1334000.0,191000.0,-118000.0,4000.0,5942000,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.28000003,0.34146345,0.82 - 2.75,-1.65,-0.59999996,0.82,2.75,1565222400,1565726400,1565726400,1565726400,-0.022,0.0,1.1 - 1.1,1.1,0.0,0.0,270,14,finmb_415118,Other OTC,Dynasil Corporation of America,USD,1671,450,1.184,1.1941667,-0.09416664,-0.07885552,1.2183334,-0.11833334,-0.09712723,16503190,0.9290541,15,America/New_York,EDT,-14400000,4,PNK,REGULAR,us_market,DYNASIL CORP OF AMERICA,1.1,1630423898,0.0,1.09,1.1,1.1,2650,0.28,,,2.75,0.82,1.1942,1.2183,1.67k,450,15M,,7.43M,50.03%,0.00%,12.57k,0.17,0.13%,0.07%,47.37k,,,,,,0.00%,"Aug 07, 2019",,2:1,"Oct 30, 1996","Sep 29, 2019","Sep 29, 2019",-0.85%,0.03%,0.02%,-1.91%,43.7M,2.56,3.30%,16.07M,1.43M,-370k,-0.0220,,268k,0.02,6.03M,32.10,1.62,1.18,-508k,-1.32M,Value,02458,Technology,207,"Dynasil Corporation of America develops, markets, manufactures, and sells detection, sensing, and analysis technology and optical components in the United States, Asia, Europe, and internationally. It operates through Optics, Innovation and Development, and Biomedical segments. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays in the medical, industrial, and homeland security/defense sectors. The Innovation and Development segment develops advanced technology in materials, sensors, and prototype instruments that detect or measure radiation, light, magnetism, or sound for use in security, medical, and industrial applications. The Biomedical segment engages in the development of tissue sealant products. The company distributes its products through direct sales and marketing staff, as well as through manufacturer's representatives and distributors. Dynasil Corporation of America was founded in 1960 and is headquartered in Newton, Massachusetts.",Newton,617-668-6855,MA,1577750400,United States,http://www.dynasil.com,86400,313 Washington Street,617-668-6992,Scientific & Technical Instruments,Suite 403
t-2,DYSL,14648000,15002900,147000,,278000,1274000,76000,3887000,4358000,324000,324000,,-46000,,,,206000,11532000,11208000,7174000,-46000,,72000,76000,701000,22060000,8619000,21249000,25000,31142000,9000,862000,385000,5900000,-1682000,4277000,350000,6536000,4198000,1307000,-696000,8020000,12244000,6522000,1660000,4525000,2218000,404000.0,-357000.0,49000.0,54000.0,97000.0,-815000.0,-3249000.0,26000.0,-538000.0,355000.0,6000.0,-1776000.0,300000.0,-357000.0,5000.0,5708000,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.28000003,0.34146345,0.82 - 2.75,-1.65,-0.59999996,0.82,2.75,1565222400,1565726400,1565726400,1565726400,-0.022,0.0,1.1 - 1.1,1.1,0.0,0.0,270,14,finmb_415118,Other OTC,Dynasil Corporation of America,USD,1671,450,1.184,1.1941667,-0.09416664,-0.07885552,1.2183334,-0.11833334,-0.09712723,16503190,0.9290541,15,America/New_York,EDT,-14400000,4,PNK,REGULAR,us_market,DYNASIL CORP OF AMERICA,1.1,1630423898,0.0,1.09,1.1,1.1,2650,0.28,,,2.75,0.82,1.1942,1.2183,1.67k,450,15M,,7.43M,50.03%,0.00%,12.57k,0.17,0.13%,0.07%,47.37k,,,,,,0.00%,"Aug 07, 2019",,2:1,"Oct 30, 1996","Sep 29, 2019","Sep 29, 2019",-0.85%,0.03%,0.02%,-1.91%,43.7M,2.56,3.30%,16.07M,1.43M,-370k,-0.0220,,268k,0.02,6.03M,32.10,1.62,1.18,-508k,-1.32M,Value,02458,Technology,207,"Dynasil Corporation of America develops, markets, manufactures, and sells detection, sensing, and analysis technology and optical components in the United States, Asia, Europe, and internationally. It operates through Optics, Innovation and Development, and Biomedical segments. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays in the medical, industrial, and homeland security/defense sectors. The Innovation and Development segment develops advanced technology in materials, sensors, and prototype instruments that detect or measure radiation, light, magnetism, or sound for use in security, medical, and industrial applications. The Biomedical segment engages in the development of tissue sealant products. The company distributes its products through direct sales and marketing staff, as well as through manufacturer's representatives and distributors. Dynasil Corporation of America was founded in 1960 and is headquartered in Newton, Massachusetts.",Newton,617-668-6855,MA,1577750400,United States,http://www.dynasil.com,86400,313 Washington Street,617-668-6992,Scientific & Technical Instruments,Suite 403
t-3,DYSL,14316000,15002900,177000,,-167000,1292000,-93000,3640000,3692000,-125000,-125000,,-42000,,,,-65000,10028000,10153000,6336000,-42000,,-102000,-93000,718000,21946000,7994000,20898000,157000,30184000,9000,770000,377000,5864000,-1827000,4451000,1165000,5675000,4394000,1253000,-841000,7956000,11195000,4737000,1898000,4492000,1669000,-769000.0,-204000.0,54000.0,59000.0,-612000.0,-1162000.0,-3249000.0,-33000.0,-984000.0,338000.0,-443000.0,560000.0,35000.0,-204000.0,5000.0,5520000,en-US,US,EQUITY,False,Delayed Quote,USD,False,False,0,0.28000003,0.34146345,0.82 - 2.75,-1.65,-0.59999996,0.82,2.75,1565222400,1565726400,1565726400,1565726400,-0.022,0.0,1.1 - 1.1,1.1,0.0,0.0,270,14,finmb_415118,Other OTC,Dynasil Corporation of America,USD,1671,450,1.184,1.1941667,-0.09416664,-0.07885552,1.2183334,-0.11833334,-0.09712723,16503190,0.9290541,15,America/New_York,EDT,-14400000,4,PNK,REGULAR,us_market,DYNASIL CORP OF AMERICA,1.1,1630423898,0.0,1.09,1.1,1.1,2650,0.28,,,2.75,0.82,1.1942,1.2183,1.67k,450,15M,,7.43M,50.03%,0.00%,12.57k,0.17,0.13%,0.07%,47.37k,,,,,,0.00%,"Aug 07, 2019",,2:1,"Oct 30, 1996","Sep 29, 2019","Sep 29, 2019",-0.85%,0.03%,0.02%,-1.91%,43.7M,2.56,3.30%,16.07M,1.43M,-370k,-0.0220,,268k,0.02,6.03M,32.10,1.62,1.18,-508k,-1.32M,Value,02458,Technology,207,"Dynasil Corporation of America develops, markets, manufactures, and sells detection, sensing, and analysis technology and optical components in the United States, Asia, Europe, and internationally. It operates through Optics, Innovation and Development, and Biomedical segments. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays in the medical, industrial, and homeland security/defense sectors. The Innovation and Development segment develops advanced technology in materials, sensors, and prototype instruments that detect or measure radiation, light, magnetism, or sound for use in security, medical, and industrial applications. The Biomedical segment engages in the development of tissue sealant products. The company distributes its products through direct sales and marketing staff, as well as through manufacturer's representatives and distributors. Dynasil Corporation of America was founded in 1960 and is headquartered in Newton, Massachusetts.",Newton,617-668-6855,MA,1577750400,United States,http://www.dynasil.com,86400,313 Washington Street,617-668-6992,Scientific & Technical Instruments,Suite 403
